Creating, guiding, connecting and funding — from concept to commercialization.

For more than three decades, Pappas Ventures has created, funded, and guided next-generation life science companies. The team pairs deep scientific and clinical judgment with hands-on company-building — helping founders translate a discovery into a therapy, a device, or a diagnostic that reaches the market.

Investments span biopharma and therapeutics, medical devices and diagnostics, agriculture, and technology, across the United States, Canada, and Asia. Our portfolio companies have brought products to market for conditions from melanoma and ovarian cancer to hemophilia and migraine.

How we partner

We invest with conviction and stay close. That means active board participation, syndicate-building with leading co-investors, and the operating experience to help a company through the inflection points that matter — first-in-human, pivotal data, regulatory approval, and commercialization.